Hiroshi Tatsukawa
- Epidemiology top 10%
-
- Autoimmune and Inflammatory Disorders Research 3
-
- Autoimmune Bullous Skin Diseases 2
-
- Adolescent and Pediatric Healthcare 2
-
- Renal Diseases and Glomerulopathies 2
-
- Systemic Lupus Erythematosus Research 2
-
- Family and Disability Support Research 2
-
- Bioactive Compounds and Antitumor Agents 1
-
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Hironobu YoshimatsuTakayuki MasakiMasataka SeikeSeiichi ChibaHitoshi NoguchiTohru YasudaShuji NaganoMiwa Haranaka
- Partner nations
- Japan
In The Last Decade
Hiroshi Tatsukawa
13 papers receiving 493 citations
Peers
Comparison fields: 5 of 69
- Epidemiology 292
- Endocrine and Autonomic Systems 47
- Hepatology 48
- Physiology 136
- Hematology 57
Countries citing papers authored by Hiroshi Tatsukawa
This map shows the geographic impact of Hiroshi Tatsukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tatsukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tatsukawa more than expected).
Fields of papers citing papers by Hiroshi Tatsukawa
This network shows the impact of papers produced by Hiroshi Tatsukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tatsukawa. The network helps show where Hiroshi Tatsukawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Tatsukawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 32 | |
| 2 | 2012 | 21 | |
| 3 | 2011 | 23 | |
| 4 | 2008 | 8 | |
| 5 | 2005 | 10 | |
| 6 | 2005 | 30 | |
| 7 | 2004 | 2 | |
| 8 | 2004 | 351 | |
| 9 | 2004 | 3 | |
| 10 | 2003 | 12 | |
| 11 | [A case of primary Sjögren's syndrome with severe pulmonary hypertension and glomerular damage]. | 2003 | 11 |
| 12 | [A case of hypertensive hypertrophy in which both regression of hypertrophy and improvement of the abnormalities in iodine-123-metaiodobenzylguanidine (MIBG) myocardial imagings were observed after antihypertensive therapy]. | 1995 | 0 |
| 13 | Attempts at cultivation of Mycobacterium leprae in cell culture under regulation of redox potential at environment. | 1982 | 1 |
| 14 | Prothionamide and prothionamide-S-oxide in experimental leprosy. | 1981 | 2 |
About Hiroshi Tatsukawa
Hiroshi Tatsukawa is a scholar working on Hematology, Rheumatology, Speech and Hearing, Toxicology and Nephrology, having authored 14 papers that have together received 506 indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (3 papers), Autoimmune Bullous Skin Diseases (2 papers), Adolescent and Pediatric Healthcare (2 papers), Renal Diseases and Glomerulopathies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Family and Disability Support Research (2 papers), Bioactive Compounds and Antitumor Agents (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Epidemiology (292 citations), Endocrine and Autonomic Systems (47 citations), Hepatology (48 citations), Physiology (136 citations) and Hematology (57 citations). Hiroshi Tatsukawa has collaborated with scholars based in Japan. Frequent co-authors include Hironobu Yoshimatsu, Takayuki Masaki, Masataka Seike, Seiichi Chiba, Hitoshi Noguchi, Tohru Yasuda, Shuji Nagano, Miwa Haranaka, Yoshikazu Umeno and Keisuke Maeshima. Their work appears in journals such as Modern Rheumatology, The FASEB Journal, Metabolism, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.